Announcements Trials
Browse Landscape

Status

Unknown 2Terminated 1

Sponsor Class

NIH 25NETWORK 3OTHER 2INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 1Breast 1

Conditions

Neoplasms 1Breast Neoplasms 1

Interventions

Injections 53Cisplatin 47Paclitaxel 46Carboplatin 41Gemcitabine 37Docetaxel 36Capecitabine 36pembrolizumab 35Drug Therapy 34anlotinib 25icotinib 23Fluorouracil 23Bevacizumab 23Cyclophosphamide 22Oxaliplatin 19fludarabine 18Pemetrexed 17Irinotecan 16Leucovorin 15Temozolomide 14Doxorubicin 14Cetuximab 14camrelizumab 13apatinib 13Nivolumab 13Trastuzumab 11Rituximab 11Etoposide 11tesetaxel 10SHR-1701 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × Gene Expression Profiling × Clear all
NCT03521245 2021-09-14

Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer

OmicsWay Corp.

Unknown
40 enrolled
Breast

Breast Neoplasms

NCT03724097 2021-09-14

Identification of Molecular Biomarkers for Cancer Target Therapy Efficacy

OmicsWay Corp.

Unknown
200 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡